PubRank

M J McLean

Author PubWeight™ 48.56‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antigen-driven B cell differentiation in vivo. J Exp Med 1993 2.35
2 Prognostic factors in small malignant melanomas of choroid and ciliary body. Arch Ophthalmol 1977 1.72
3 The segment inversion site of herpes simplex virus type 1 adopts a novel DNA structure. J Biol Chem 1987 1.54
4 Proteome composition and codon usage in spirochaetes: species-specific and DNA strand-specific mutational biases. Nucleic Acids Res 1999 1.47
5 Consecutive A X T pairs can adopt a left-handed DNA structure. Proc Natl Acad Sci U S A 1986 1.33
6 Two configurations of static magnetic fields for treating rheumatoid arthritis of the knee: a double-blind clinical trial. Arch Phys Med Rehabil 2001 1.30
7 Regional distribution of protease-resistant prion protein in fatal familial insomnia. Ann Neurol 1995 1.26
8 Diethyl pyrocarbonate can detect a modified DNA structure induced by the binding of quinoxaline antibiotics. Nucleic Acids Res 1988 1.18
9 Carbamazepine and 10,11-epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther 1986 1.17
10 Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action. Epilepsia 1994 1.06
11 Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine. J Med Chem 1986 1.01
12 Anticonvulsant drugs: mechanisms of action. Adv Neurol 1986 0.97
13 Mechanism for the postive inotropic effect of angiotensin II on isolated cardiac muscle. Circ Res 1976 0.95
14 Multiple actions of phenytoin on mouse spinal cord neurons in cell culture. J Pharmacol Exp Ther 1983 0.95
15 Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther 1986 0.94
16 The 2-amino group of guanine is absolutely required for specific binding of the anti-cancer antibiotic echinomycin to DNA. Nucleic Acids Res 1992 0.94
17 Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group. Seizure 2000 0.92
18 Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures. Eur J Pharmacol 1994 0.90
19 Characteristics of triplex-directed photoadduct formation by psoralen-linked oligodeoxynucleotides. Nucleic Acids Res 1995 0.89
20 The production of PCR products with 5' single-stranded tails using primers that incorporate novel phosphoramidite intermediates. Nucleic Acids Res 1993 0.88
21 Inhibition of aromatase expression by a psoralen-linked triplex-forming oligonucleotide targeted to a coding sequence. FEBS Lett 1995 0.87
22 Sequence-selective, pH-dependent binding to DNA of benzophenanthridine alkaloids. J Mol Recognit 1990 0.87
23 Multiple DNA secondary structures in perfect inverted repeat inserts in plasmids. Right-handed B-DNA, cruciforms, and left-handed Z-DNA. J Biol Chem 1988 0.87
24 Two pharmacological types of cardiac slow Na+ channels as distinguished by verapamil. Eur J Pharmacol 1974 0.87
25 Measurement and analysis of static magnetic fields that block action potentials in cultured neurons. Bioelectromagnetics 1995 0.85
26 Messenger RNA induction of fast sodium ion channels in cultured cardiac myoblasts. Science 1976 0.83
27 Ralitoline (CI-946) and CI-953 block sustained repetitive sodium action potentials in cultured mouse spinal cord neurons and displace batrachotoxinin A 20-alpha-benzoate binding in vitro. Epilepsy Res 1991 0.83
28 Phenytoin blocks N-methyl-D-aspartate responses of mouse central neurons. J Pharmacol Exp Ther 1993 0.83
29 Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture. Epilepsy Res 1994 0.83
30 Diazepam and its anomalous p-chloro-derivative Ro 5-4864: comparative effects on mouse neurons in cell culture. Brain Res 1984 0.83
31 Retention of fully differentiated electrophysiological properties of chick embryonic heart cells in culture. Dev Biol 1976 0.83
32 Electrical properties of cultured heart cells. Recent Adv Stud Cardiac Struct Metab 1978 0.82
33 High cyclic AMP levels in young chick embryonic hearts. Dev Biol 1975 0.82
34 Cellular bases of barbiturate and phenytoin anticonvulsant drug action. Epilepsia 1982 0.82
35 Acetazolamide for the treatment of chronic paroxysmal hemicrania. Headache 1995 0.82
36 Anticonvulsant drug mechanisms of action. Fed Proc 1985 0.82
37 Electrophysiological recordings from spontaneously contracting reaggregates of cultured vascular smooth muscle cells from chick enbryos. Exp Cell Res 1977 0.81
38 Fatal familial insomnia: clinical and pathologic heterogeneity in genetic half brothers. Neurology 1998 0.80
39 Use-, concentration- and voltage-dependent limitation by MK-801 of action potential firing frequency in mouse central neurons in cell culture. J Pharmacol Exp Ther 1992 0.80
40 The dynamics of T cell-dependent B cell responses in vivo. Immunol Cell Biol 1992 0.80
41 Response of moyamoya disease to verapamil. Lancet 1985 0.79
42 Membrane differentiation of cardiac myoblasts induced in vitro by an RNA-enriched fraction from adult heart. Exp Cell Res 1977 0.79
43 Differences in degree of electrotonic interaction in highly differentiated and reverted cultured heart cell reaggregates. J Membr Biol 1980 0.78
44 Static magnetic field therapy for pain in the abdomen and genitals. Pediatr Neurol 2000 0.78
45 Remacemide HCl and its metabolite, FPL 12495AA, limit action potential firing frequency and block NMDA responses of mouse spinal cord neurons in cell culture. Epilepsy Res 1996 0.78
46 A PrP gene codon 178 base substitution and a 24-bp interstitial deletion in familial Creutzfeldt-Jakob disease. Neurology 1992 0.77
47 Rapid loss of sensitivity to tetrodotoxin by chick ventricular myocardial cells after separation from the heart. Exp Cell Res 1974 0.76
48 Reagents for the preparation of two oligonucleotides per synthesis (TOPS). Nucleic Acids Res 1994 0.76
49 Trans-2-en-valproic acid limits action potential firing frequency in mouse central neurons in cell culture. J Pharmacol Exp Ther 1997 0.76
50 Electrophysiological recordings from spontaneously contracting reaggregates of cultured smooth muscle cells from guinea pig vas deferens. J Cell Biol 1979 0.75
51 Mechanisms of anticonvulsant drug action. Electroencephalogr Clin Neurophysiol Suppl 1987 0.75
52 Cellular mechanistic bases for classification of clinically useful anticonvulsant drugs. Ann Acad Med Singapore 1985 0.75
53 The Marinesco-Sjögren syndrome examined by computed tomography, magnetic resonance, and 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography. Arch Neurol 1990 0.75
54 Treatment of acute deficits of moyamoya disease with verapamil. Ann Acad Med Singapore 1985 0.75
55 Effect of temperature on limitation by MK-801 of firing of action potentials by spinal cord neurons in cell culture. Eur J Pharmacol 1993 0.75
56 Cardiac-like action potentials recorded from spontaneously-contractiong structures induced in post-nodal pieces of chick blastoderm exposed to an RNA-enriched fraction from adult heart. Differentiation 1978 0.75
57 Effect of environmental stress and surface treatment on resin-to-metal bonding. Am J Dent 1993 0.75